Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the ...
Aberdeen school pupils were given the opportunity to develop key skills that could shape their future careers during a visit to an international technology centre.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback